|
[PMID]: | 28602540 |
[Au] Autor: | Luz AL; Godebo TR; Smith LL; Leuthner TC; Maurer LL; Meyer JN |
[Ad] Endereço: | Nicholas School of the Environment, Box 90328, Duke University, Durham, NC, 27708, USA. |
[Ti] Título: | Deficiencies in mitochondrial dynamics sensitize Caenorhabditis elegans to arsenite and other mitochondrial toxicants by reducing mitochondrial adaptability. |
[So] Source: | Toxicology;387:81-94, 2017 Jul 15. | [Is] ISSN: | 1879-3185 |
[Cp] País de publicação: | Ireland |
[La] Idioma: | eng |
[Ab] Resumo: | Mitochondrial fission, fusion, and mitophagy are interlinked processes that regulate mitochondrial shape, number, and size, as well as metabolic activity and stress response. The fundamental importance of these processes is evident in the fact that mutations in fission (DRP1), fusion (MFN2, OPA1), and mitophagy (PINK1, PARK2) genes can cause human disease (collectively >1/10,000). Interestingly, however, the age of onset and severity of clinical manifestations varies greatly between patients with these diseases (even those harboring identical mutations), suggesting a role for environmental factors in the development and progression of certain mitochondrial diseases. Using the model organism Caenorhabditis elegans, we screened ten mitochondrial toxicants (2, 4-dinitrophenol, acetaldehyde, acrolein, aflatoxin B , arsenite, cadmium, cisplatin, doxycycline, paraquat, rotenone) for increased or decreased toxicity in fusion (fzo-1, eat-3)-, fission (drp-1)-, and mitophagy (pdr-1, pink-1)-deficient nematodes using a larval growth assay. In general, fusion-deficient nematodes were the most sensitive to toxicants, including aflatoxin B , arsenite, cisplatin, paraquat, and rotenone. Because arsenite was particularly potent in fission- and fusion-deficient nematodes, and hundreds of millions of people are chronically exposed to arsenic, we investigated the effects of these genetic deficiencies on arsenic toxicity in more depth. We found that deficiencies in fission and fusion sensitized nematodes to arsenite-induced lethality throughout aging. Furthermore, low-dose arsenite, which acted in a "mitohormetic" fashion by increasing mitochondrial function (in particular, basal and maximal oxygen consumption) in wild-type nematodes by a wide range of measures, exacerbated mitochondrial dysfunction in fusion-deficient nematodes. Analysis of multiple mechanistic changes suggested that disruption of pyruvate metabolism and Krebs cycle activity underlie the observed arsenite-induced mitochondrial deficits, and these disruptions are exacerbated in the absence of mitochondrial fusion. This research demonstrates the importance of mitochondrial dynamics in limiting arsenite toxicity by permitting mitochondrial adaptability. It also suggests that individuals suffering from deficiencies in mitodynamic processes may be more susceptible to the mitochondrial toxicity of arsenic and other toxicants. |
[Mh] Termos MeSH primário: |
Arsenitos/toxicidade Proteínas de Caenorhabditis elegans/metabolismo Caenorhabditis elegans/efeitos dos fármacos Mitocôndrias/efeitos dos fármacos Dinâmica Mitocondrial/efeitos dos fármacos Compostos de Sódio/toxicidade
|
[Mh] Termos MeSH secundário: |
Animais Autofagia/efeitos dos fármacos Caenorhabditis elegans/embriologia Caenorhabditis elegans/genética Caenorhabditis elegans/metabolismo Proteínas de Caenorhabditis elegans/genética Relação Dose-Resposta a Droga Dinaminas/genética Dinaminas/metabolismo GTP Fosfo-Hidrolases/genética GTP Fosfo-Hidrolases/metabolismo Interação Gene-Ambiente Genótipo Larva/efeitos dos fármacos Larva/metabolismo Mitocôndrias/metabolismo Degradação Mitocondrial/efeitos dos fármacos Fenótipo Proteínas Serina-Treonina Quinases/genética Proteínas Serina-Treonina Quinases/metabolismo Ubiquitina-Proteína Ligases/genética Ubiquitina-Proteína Ligases/metabolismo
|
[Pt] Tipo de publicação: | JOURNAL ARTICLE |
[Nm] Nome de substância:
| 0 (Arsenites); 0 (Caenorhabditis elegans Proteins); 0 (Sodium Compounds); 48OVY2OC72 (sodium arsenite); EC 2.3.2.27 (Ubiquitin-Protein Ligases); EC 2.3.2.27 (parkin protein); EC 2.7.11.1 (PINK1 protein, C elegans); EC 2.7.11.1 (Protein-Serine-Threonine Kinases); EC 3.6.1.- (EAT-3 protein, C elegans); EC 3.6.1.- (FZO-1 protein, C elegans); EC 3.6.1.- (GTP Phosphohydrolases); EC 3.6.5.5 (Dynamins); EC 3.6.5.5 (dynamin-related protein 1, C elegans) |
[Em] Mês de entrada: | 1707 |
[Cu] Atualização por classe: | 170801 |
[Lr] Data última revisão:
| 170801 |
[Sb] Subgrupo de revista: | IM |
[Da] Data de entrada para processamento: | 170613 |
[St] Status: | MEDLINE |
|
|
|